1. Home
  2. SLNO vs RELY Comparison

SLNO vs RELY Comparison

Compare SLNO & RELY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • RELY
  • Stock Information
  • Founded
  • SLNO 1999
  • RELY 2011
  • Country
  • SLNO United States
  • RELY United States
  • Employees
  • SLNO N/A
  • RELY N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RELY Computer Software: Prepackaged Software
  • Sector
  • SLNO Health Care
  • RELY Technology
  • Exchange
  • SLNO Nasdaq
  • RELY Nasdaq
  • Market Cap
  • SLNO 3.8B
  • RELY 3.5B
  • IPO Year
  • SLNO 2014
  • RELY 2021
  • Fundamental
  • Price
  • SLNO $68.57
  • RELY $19.05
  • Analyst Decision
  • SLNO Strong Buy
  • RELY Buy
  • Analyst Count
  • SLNO 10
  • RELY 9
  • Target Price
  • SLNO $112.50
  • RELY $27.22
  • AVG Volume (30 Days)
  • SLNO 1.6M
  • RELY 4.5M
  • Earning Date
  • SLNO 08-06-2025
  • RELY 08-06-2025
  • Dividend Yield
  • SLNO N/A
  • RELY N/A
  • EPS Growth
  • SLNO N/A
  • RELY N/A
  • EPS
  • SLNO N/A
  • RELY 0.06
  • Revenue
  • SLNO $32,656,999.00
  • RELY $1,461,898,000.00
  • Revenue This Year
  • SLNO N/A
  • RELY $27.77
  • Revenue Next Year
  • SLNO $209.31
  • RELY $20.62
  • P/E Ratio
  • SLNO N/A
  • RELY $302.27
  • Revenue Growth
  • SLNO N/A
  • RELY 35.12
  • 52 Week Low
  • SLNO $41.50
  • RELY $12.43
  • 52 Week High
  • SLNO $90.32
  • RELY $27.32
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 32.58
  • RELY 55.79
  • Support Level
  • SLNO $66.72
  • RELY $18.54
  • Resistance Level
  • SLNO $87.17
  • RELY $20.15
  • Average True Range (ATR)
  • SLNO 3.81
  • RELY 0.61
  • MACD
  • SLNO -1.52
  • RELY 0.11
  • Stochastic Oscillator
  • SLNO 21.55
  • RELY 73.59

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Share on Social Networks: